Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.
An expert who studies stocks thinks LifeStance Health is a good company and believes it might be worth more money in the future—going from $13 to $15 per share. This suggests the analyst sees the company doing well, so it's worth paying attention to how the business is actually performing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.